ALNY (Alnylam Corp) Forvard P/S multiplikatori

Alnylam Pharmaceuticals (ALNY) korporativ emblemasi va logotipi

Alnylam Pharmaceuticals (ALNY) RNA interferentsiyasi sohasidagi biofarmatsevtika gigantlari bilan hamkorlik orqali o'sishni rag'batlantirmoqda, bu esa GURU.Markets grafik ma'lumotlaridagi forward P/S tendentsiyasini tasdiqlaydi, bunda 10.00 ushbu metrikaning joriy qiymatidir. Kompaniya o'z g'oyalarini litsenziyalash va gen terapiyasi orqali monetizatsiya qilmoqda, shu bilan birga uning strategiyasi kam uchraydigan patologiyalardan ommaviy kardiovaskular bozorlariga qarab o'zgarib, investorlar uchun yangi imkoniyatlar yaratmoqda.

Alnylam - ALNY Forvard P/S multiplikatori (davr: 04.07.2022 - 16.11.2026)

Alnylam Pharmaceuticals (ALNY) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning fundamental tahlili:Alnylam Pharmaceuticals, Inc. ALNY
Alnylam Corp original mahsuloti

Ushbu koeffitsiyent qadrsizlangan qimmatli qog'ozlarni qidirishda aktivlar qiymatini baholash uchun stress-test vositasi bo'lib xizmat qiladi. U kelajakdagi daromadlar o'sishi uchun investor to'lashga tayyor bo'lgan premiumni aniqlash maqsadida joriy bozor kapitalizatsiyasini kutilayotgan savdo hajmi bilan solishtiradi. Alnylam Pharmaceuticals (ALNY) uchun forward P/S ko'rsatkichi daromadning tor portfelga bog'liqligi va klinik sinovlarning so'nggi bosqichlaridagi muvaffaqiyatsizliklar xavfi bo'yicha bozor xavotirlarini aks ettiradi.

Alnylam Pharmaceuticals raqobatchilari

Narxning prognoz qilingan daromadga nisbati Vertex VRTX|INSM (Insmed Inc) - Kelajakdagi narxning daromadga nisbati|United Therapeutics - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx BMRN (BioMarin Pharmaceutical)|BBIO: Forvard P/S multiplikatori|BGM Group Corp - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Cogent Bio|XERS: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati kerostx.com (KROS)|Forvard narx/daromad multiplikatori Arcturus Therapeutics ARCT|Forvard P/S multiplikatori ETON (etonpharma.com)|Forvard P/S multiplikatori Kamada Ltd KMDA|Fulcrum Therapeutics, Inc. - Forvard P/S multiplikatori|ABEO - Forvard P/S multiplikatori|MREO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Protalix BioTherapeutics, Inc. (PLX)|PLRX (Pliant Therapeutics, Inc.) - Forvard P/S multiplikatori|Applied Therapeutics Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Rein Therapeutics Inc (RNTX)|Narxning kutilayotgan daromadga nisbati GELS|Aytu BioPharma, Inc. - Forvard narx/daromad multiplikatori|Chemomab Therapeutics (CMMB) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SRx Health - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Polyrizon Limited PLRZ|AEZS: Forvard P/S multiplikatori|CYTH: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori INZY|RPHM: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CSCI (COSCIENS Biopharma)